Policy and Development Policy and Development of Biotechnology: of Biotechnology:

Bangladesh PerspectiveBangladesh Perspective

N. ChoudhuryBangladesh Academy of Sciences

06 April 2004 Biotechnology Presentation Dr. N Choudhury 3

WCS RecommendationWCS Recommendation

National policies should be adopted that imply consistent and long term support to S&T, in order to ensure strengthening of human resource base, establishment of scientific institutions, improve and upgrading of science education, integration of science into national culture, development of infrastructure and promotion of technology and innovation capacities.

06 April 2004 Biotechnology Presentation Dr. N Choudhury 4

Policy and actionPolicy and action--ContradictionContradiction

The broad recommendations in the policy document did not have the adequate analytical framework or implementation strategy for addressing the nature of problems faced by the S&T sector and the recommendations were not based on expenditure, benefits constraints etc. Science and technology enjoyed rhetorical support from all the successive governments. There were encouraging utterances for S&T development from time to time from political leaders but there were little or no follow up actions to match the words

06 April 2004 Biotechnology Presentation Dr. N Choudhury 5

Major challenges for Major challenges for developing countriesdeveloping countries

Capital intensivenessSpecialized laboratory structureCommercialisation issuesPrivate sector shynessBiosafety issuesBioethical issues

06 April 2004 Biotechnology Presentation Dr. N Choudhury 6

Genetic Engineering Genetic Engineering ProductsProducts

Transgenic PlantsFood IngredientsStarter culturesSaccharomyees cerevisiaePeptide growth hormonesTransgenic AnimalsAntisense TechnologyCancer Imaging AgentsRecombinant Dairy ProductsAutoimmune Therapeutics

Immunoassays for Pesticide Residue TestsDiabetes TherapyNew Products of Promise for Chicken IndustryGrowth/Healing ProteinsHazardous Waste TreatmentHuman GenomeGolden Rice Biofarming

06 April 2004 Biotechnology Presentation Dr. N Choudhury 7

New Products MarketedNew Products Marketed

Tissue Plasminogenactivator (t-PA): Erythropoiethin (EPO): Used for cancer.Interleukin-2 (IL-2): Used for cancer.Monoclonal antibodies for detecting and treating Cancer Cells. Protein engineering

Monoclonal antibodies against septic shockAIDS treatmentGenetically engineered bacteria for agricultureRecombinant products for healthBroadening goals of plant genetic engineers

06 April 2004 Biotechnology Presentation Dr. N Choudhury 8

Advancements of Industrial Advancements of Industrial biotechnologybiotechnology

Protein EngineeringFood IngredientsStarter Cultures for bakery ProductsPeptide growth HormonesImprovement of Auditioned qualityCancer Imaging agentsRecombinant Dairy ProductsAutoimmune therapeuticsGrowth / Healing Protein

06 April 2004 Biotechnology Presentation Dr. N Choudhury 9

Some important Some important developments of human developments of human

drugs drugs Human InsulinHuman growth Hormone InterferonInter IeukinsTissue Plasmiagen activators.Hepatitis B vaccineBlood factor VIII: CMonoclonal antibodies

06 April 2004 Biotechnology Presentation Dr. N Choudhury 10

Present Status of Present Status of Biotechnology in Biotechnology in

BangladeshBangladeshPlant BiotechnologyAnimal Biotechnology & AquacultureInsect BiotechnologyIndustrial BiotechnologyBioenergy and Bioconversion TechnologyEnvironmental BiotechnologyGenetic Engineering

06 April 2004 Biotechnology Presentation Dr. N Choudhury 11

R&D Priorities For R&D Priorities For Biotechnology And Biotechnology And

Genetic EngineeringGenetic EngineeringHealth sectorIndustry SectorAgriculture SectorEnergy sectorEnvironment sectorManufacturing/Bioprocessing Marine Biotechnology and Aquaculture

06 April 2004 Biotechnology Presentation Dr. N Choudhury 12

National Institute of National Institute of BiotechnologyBiotechnology

Estimated cost: 2768.24 lakh Taka(Revised)Total Area of Institute Building: 3700 sq. m. Total Floor space of the Laboratories: 2250 sq. m.

No. Of Laboratory: 6Total No. Of Scientists to work: 100Expected year of completion: June 2004.

06 April 2004 Biotechnology Presentation Dr. N Choudhury 13

Proposed Laboratories / Proposed Laboratories / Divisions Divisions

DNA LaboratoryPlant BiotechnologyAnimal BiotechnologyFish BiotechnologyFermentation and Bioprocessing Bio-energy and Fertilization

06 April 2004 Biotechnology Presentation Dr. N Choudhury 14

BioBio--safety guidelinessafety guidelines

Procedures and guidelines on the introduction movement and field release of regulated materials.Physico-chemical and biological containment procedures and facilities. Guidelines for classification of microorganisms according to their risk assessment.

06 April 2004 Biotechnology Presentation Dr. N Choudhury 15

BioBio--safety guidelines safety guidelines (Cont.)(Cont.)

Good laboratory Practices.Good Industrial large-scale practice.List of organisms according to different risk groups.The Universal Biohazard sign.Framework for risk assessment. Biosafety Committees.

06 April 2004 Biotechnology Presentation Dr. N Choudhury 16

Biotechnology Biotechnology Opportunities and Opportunities and

ChallengesChallengesCapital intensivenessSpecialized laboratory structureCommercialisation issuesPrivate sector shynessBiosafety issuesBioethical issues

06 April 2004 Biotechnology Presentation Dr. N Choudhury 17

National Capacity BuildingNational Capacity Building

Infrastructure developmentManpower developmentEquipmentsFine chemicals

06 April 2004 Biotechnology Presentation Dr. N Choudhury 18

Infrastructure developmentInfrastructure development

Laboratory buildingAncillary facilitiesSpecialized laboratories etc.

06 April 2004 Biotechnology Presentation Dr. N Choudhury 19

Manpower developmentManpower development

Specialized expertise in the field of

Molecular biologyGenetic EngineeringProtein ChemistryChemical Engineering etc.

06 April 2004 Biotechnology Presentation Dr. N Choudhury 20

EquipmentsEquipments

DNA synthesizersProtein SequencersHigh-speed ultracentrifugePilot plant equipment for plantAnimal and microbial technology work etc.

06 April 2004 Biotechnology Presentation Dr. N Choudhury 21

Fine chemicalsFine chemicals

A regular supply of costly chemicalsenzymesradio labelled compounds

06 April 2004 Biotechnology Presentation Dr. N Choudhury 22

A 20A 20--year perspective planyear perspective planManpower developmentLaboratory infrastructure developmentBuilding centre for excellenceIdentification of priority Research areas like

agriculture biotechnologyhealthcare, industrial biotechnologybio-energybioremediation etc.

06 April 2004 Biotechnology Presentation Dr. N Choudhury 23

Related IssuesRelated Issues

Biosafety and bioethicsTechnology transfer and IPRBiodiversityPublic awareness

The EndThe EndThank you